Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > beta-NGF


Brief Information

Name:Nerve growth factor
Target Synonym:Nerve Growth Factor
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:13
Lastest Research Phase:NDA/BLA

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
BEF-M5213 Mouse Mouse Beta-NGF Protein, Tag Free (MALS verified)
BEF-H5214 Human Human Beta-NGF Protein, premium grade
ACRO Quality

Part of Bioactivity data

BEF-H5214-Cell-based assay

Human Beta-NGF Protein, premium grade (Cat. No. BEF-H5214) stimulates proliferation of TF-1 cells. The EC50 for this effect is 2.963 ng/mL (Routinely tested).


Immobilized Human Beta-NGF Protein, premium grade (Cat. No. BEF-H5214) at 1 μg/mL (100 μL/well) can bind Human TrkA (33-417), Mouse IgG2a Fc Tag (Cat. No. TRA-H5259) with a linear range of 1-16 ng/mL (QC tested).

Beta-NGF MALS images

The purity of Mouse Beta-NGF Protein, Tag Free (Cat. No. BEF-M5213) is more than 90% and the molecular weight of this protein is around 28-36 kDa verified by SEC-MALS.

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
RGN-259 Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4 Phase 3 Clinical National Institutes Of Health Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica Details
Fasinumab SAR-164877; MT-5547; R-475; REGN-475 Phase 3 Clinical Regeneron Pharmaceuticals Inc Abdominal Pain; Sciatica; Osteoarthritis, Knee; Back Pain; Osteoarthritis; Low Back Pain; Osteoarthritis, Hip Details
MEDI-7352 MEDI-7352 Phase 2 Clinical Medimmune Chronic Pain; Diabetic Neuropathies; Osteoarthritis, Knee Details
N-Hexacosanol tCFA15; TAC-302 Phase 2 Clinical Meiji Seika Pharma Co Ltd Urinary Bladder, Underactive; Urinary Bladder, Overactive Details
Antibodies to humanized nerve growth factor(Shenyang Sunshine Pharmaceutical) Phase 2 Clinical Shenyang Sunshine Pharmaceutical Co Ltd Bone metastases; Cancer Pain Details
EP-9001A EP-9001A Phase 2 Clinical Chengdu Youluo Biotechnology Co Ltd Bone metastases; Cancer Pain; Pain Details
DS-002 DS-002 Phase 2 Clinical Dartsbio Pharmaceuticals Ltd Pain; Cancer Pain Details
Atinumab NG-101; ATI-355 Phase 2 Clinical Novartis Pharma Ag Spinal Cord Injuries; Gastroparesis; Diabetic Gastroparesis Details
Luvagrobart AK-115 Phase 1 Clinical Zhongshan Akeso Biopharma Co Ltd Pain; Cancer Pain Details
TNM-009 TNM-009; TNM009 Phase 1 Clinical Zhuhai Trinomab Pharmaceutical Co Ltd Cancer Pain; Pain Details
SMR-7694 SMR-7694; SMR7694 Phase 1 Clinical Sinobioway Biomedicine Co Ltd Osteoarthritis Details
Neuroregenerative agents (iNtRON Biotechnology) Clinical Intron Biotechnology Nervous System Diseases Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message